Your browser doesn't support javascript.
loading
Systematical analysis reveals a strong cancer relevance of CREB1-regulated genes.
Zheng, Tianyu; Huang, Jinrong; Xiang, Xi; Li, Siyuan; Yu, Jiaying; Qu, Kunli; Xu, Zhe; Han, Peng; Dong, Zhanying; Liu, Yang; Xu, Fengping; Yang, Huanming; Jäättelä, Marja; Luo, Yonglun; Liu, Bin.
Afiliação
  • Zheng T; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Huang J; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
  • Xiang X; Department of Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Li S; BGI-Shenzhen, Shenzhen, China, 518083.
  • Yu J; Department of Biomedicine, Aarhus University, 8000, Aarhus, Denmark.
  • Qu K; Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Xu Z; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
  • Han P; Department of Biomedicine, Aarhus University, 8000, Aarhus, Denmark.
  • Dong Z; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Liu Y; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
  • Xu F; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Yang H; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
  • Jäättelä M; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
  • Luo Y; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Liu B; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, China.
Cancer Cell Int ; 21(1): 530, 2021 Oct 12.
Article em En | MEDLINE | ID: mdl-34641874
The transcription factor cyclic-AMP response element-binding protein 1 (CREB1) responds to cAMP level and controls the expression of target genes, which regulates nutrition partitioning. The promoters of CREB1-targeted genes responsive to cAMP have been extensively investigated and characterized with the presence of both cAMP response element and TATA box. Compelling evidence demonstrates that CREB1 also plays an essential role in promoting tumor development. However, only very few genes required for cell survival, proliferation and migration are known to be constitutively regulated by CREB1 in tumors. Their promoters mostly do not harbor any cAMP response element. Thus, it is very likely that CREB1 regulates the expressions of distinct sets of target genes in normal tissues and tumors. The whole gene network constitutively regulated by CREB1 in tumors has remained unrevealed. Here, we employ a systematical and integrative approach to decipher this gene network in the context of both tissue cultured cancer cells and patient samples. We combine transcriptomic, Rank-Rank Hypergeometric Overlap, and Chipseq analysis, to define and characterize CREB1-regulated genes in a multidimensional fashion. A strong cancer relevance of those top-ranked targets, which meet the most stringent criteria, is eventually verified by overall survival analysis of cancer patients. These findings strongly suggest the importance of genes constitutively regulated by CREB1 for their implicative involvement in promoting tumorigenesis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancer Cell Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancer Cell Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China